However, human clinical evidence is still limited, and larger, well-controlled trials are needed to clarify safety, efficacy, and appropriate use
The only published dosing protocol is from mouse studies: 5 mg/kg by intraperitoneal injection, given intermittently over weeks
IL-10 suppresses the production of IFN-, TNF-, and IL-12 and also works to block actions of antigen-presenting cells ( The antimycobacterial effects of PZA and INH has been well established., but our lab wanted to specifically test the effects of these first-line antibiotics at 1/10 the minimum inhibitory concentration against M
Our AI advisor provides instant answers about which peptide works best for your situation, how to choose between similar options, and whether to start with one peptide or stack multiple
The enhanced surface targeting of LaccID was further confirmed by antibody staining, with and without membrane permeabilization, followed by FACS analysis (Supplementary Fig